Fusion Protein Technologies for Biopharmaceuticals 2013
DOI: 10.1002/9781118354599.ch26
|View full text |Cite
|
Sign up to set email alerts
|

Cell‐Penetrating Peptide Fusion Proteins

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 137 publications
0
1
0
Order By: Relevance
“…As new applications of Cas9 emerge, there is a growing necessity for the development of new methods for the safe and efficient delivery of the Cas9 ribonucleoprotein inside living cells. 18 Despite having shown great efficiency for the transport of other functional proteins, 40 , 41 cell-penetrating peptides have not been described in the supramolecular delivery of the Cas9 ribonucleoprotein. The report by Ramakrishna et al required the fusion of the cationic polyarginine to the C-terminal Cys introduced in the Sp Cas9 sequence.…”
Section: Discussionmentioning
confidence: 99%
“…As new applications of Cas9 emerge, there is a growing necessity for the development of new methods for the safe and efficient delivery of the Cas9 ribonucleoprotein inside living cells. 18 Despite having shown great efficiency for the transport of other functional proteins, 40 , 41 cell-penetrating peptides have not been described in the supramolecular delivery of the Cas9 ribonucleoprotein. The report by Ramakrishna et al required the fusion of the cationic polyarginine to the C-terminal Cys introduced in the Sp Cas9 sequence.…”
Section: Discussionmentioning
confidence: 99%